Clare Bankhead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Clare Bankhead has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
- Brian David Nicholson
Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK
16 shared publications - Frederick David Richard Hobbs
University of Oxford
14 shared publications - Rafael Perera
Nuffield Department of Primary Care Health Sciences, Centre for Evidence-Based Medicine, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK
10 shared publications - Jason Oke
Department of Primary Health Care Sciences, University of Oxford, Oxford, UK
7 shared publications - Margaret Smith
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
7 shared publications - Simon de Lusignan
Affiliations Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom, Royal College of General Practitioners, London, United Kingdom
7 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (9) , e1004956
Blood test trend versus single threshold abnormality to discriminate cancer from non-cancer in patients with unexpected weight loss: A retrospective cohort study
Background: Unexpected weight loss (UWL) is a non-specific cancer symptom. Abnormalities in the most recent blood test contribute to cancer referral decisions in primary care. Interpreting historical changes (trends) in blood tests could enhance discrimination for undiagnosed cancer. We aimed to assess the discrimination of blood test trend for undiagnosed cancer and compare this to that of blood test abnormality in patients presenting to primary care with UWL. Methods and findings: We conducted a retrospective cohort study of patients presenting to English primary care with UWL aged ≥18 years between 01/01/2000 and 31/12/2018 in the Clinical Practice Research Datalink. We extracted all quantitative results for 26 blood tests prior to the date of UWL. Overall and site-specific cancer diagnosis was ascertained using linked National Cancer Registrations Data. Cox models, unadjusted and adjusted for age and sex, estimated cancer risk based on blood test abnormalities (such as low albumin or raised platelets) co-occurring with UWL and joint models assessed trends in each blood test over 1-, 3-, 5-, and 10-year periods prior to UWL. The area under the curve (AUC) was used to assess discrimination, with 95% confidence intervals (CIs). Amongst 275,205 UWL patients, 5.0% ( n = 13,798) with cancer, the median (interquartile range (IQR)) number of blood tests per person over the 10 years ranged from 2 (IQR [12–3]) for 3 types of tests to 4 (IQR [2–7]) for 12 types of tests. The median (IQR) time between the first and last blood test per person was 5.2 (IQR [1.5–8.2]) years cases and 4.3 (IQR [1.0–7.7]) years for those cancer-free. The median time between the last blood test and UWL per person was 0.1 (IQR [0.0–0.6]) years for cases and 0.3 (IQR [0.0–1.1]) years for those cancer-free. Adjusted blood test abnormalities and trends were more discriminative than the unadjusted equivalent. Adjustment resulted in higher AUCs for trend compared to the equivalent blood test abnormality on 34 occasions, with highest AUC of 0.82 (95% CI [0.81, 0.83]). This included 26 trends for cancer overall, mean cell volume trend for bowel cancer and lymphoma, white blood count and neutrophil trend for lung cancer, and aspartate aminotransferase, red blood cell count, haematocrit, and platelet-to-lymphocyte ratio trend for prostate cancer. A limitation of our modelling strategy is that it did not take into account the bias in who was tested and our trend analysis was also restricted to patients with 2 or more tests in each trend window. Conclusions: Blood test abnormalities should be interpreted after age and sex adjustment to improve triage for cancer investigation in patients attending primary care with UWL. Evaluating historical trend offers further discrimination after adjustment for some test-cancer combinations.
- 17 September 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (9) , e1004956
Open AccessBlood test trend versus single threshold abnormality to discriminate cancer from non-cancer in patients with unexpected weight loss: A retrospective cohort study
Background: Unexpected weight loss (UWL) is a non-specific cancer symptom. Abnormalities in the most recent blood test contribute to cancer referral decisions in primary care. Interpreting historical changes (trends) in blood tests could enhance discrimination for undiagnosed cancer. We aimed to assess the discrimination of blood test trend for undiagnosed cancer and compare this to that of blood test abnormality in patients presenting to primary care with UWL. Methods and findings: We conducted a retrospective cohort study of patients presenting to English primary care with UWL aged ≥18 years between 01/01/2000 and 31/12/2018 in the Clinical Practice Research Datalink. We extracted all quantitative results for 26 blood tests prior to the date of UWL. Overall and site-specific cancer diagnosis was ascertained using linked National Cancer Registrations Data. Cox models, unadjusted and adjusted for age and sex, estimated cancer risk based on blood test abnormalities (such as low albumin or raised platelets) co-occurring with UWL and joint models assessed trends in each blood test over 1-, 3-, 5-, and 10-year periods prior to UWL. The area under the curve (AUC) was used to assess discrimination, with 95% confidence intervals (CIs). Amongst 275,205 UWL patients, 5.0% ( n = 13,798) with cancer, the median (interquartile range (IQR)) number of blood tests per person over the 10 years ranged from 2 (IQR [12–3]) for 3 types of tests to 4 (IQR [2–7]) for 12 types of tests. The median (IQR) time between the first and last blood test per person was 5.2 (IQR [1.5–8.2]) years cases and 4.3 (IQR [1.0–7.7]) years for those cancer-free. The median time between the last blood test and UWL per person was 0.1 (IQR [0.0–0.6]) years for cases and 0.3 (IQR [0.0–1.1]) years for those cancer-free. Adjusted blood test abnormalities and trends were more discriminative than the unadjusted equivalent. Adjustment resulted in higher AUCs for trend compared to the equivalent blood test abnormality on 34 occasions, with highest AUC of 0.82 (95% CI [0.81, 0.83]). This included 26 trends for cancer overall, mean cell volume trend for bowel cancer and lymphoma, white blood count and neutrophil trend for lung cancer, and aspartate aminotransferase, red blood cell count, haematocrit, and platelet-to-lymphocyte ratio trend for prostate cancer. A limitation of our modelling strategy is that it did not take into account the bias in who was tested and our trend analysis was also restricted to patients with 2 or more tests in each trend window. Conclusions: Blood test abnormalities should be interpreted after age and sex adjustment to improve triage for cancer investigation in patients attending primary care with UWL. Evaluating historical trend offers further discrimination after adjustment for some test-cancer combinations.
- Open Access
- 1 September 2026
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 108-B (9) , 1138-1146
Risk of venous thromboembolism after knee, hip, or shoulder arthroplasty
Aims: Arthroplasty is a widely used surgery for end-stage arthritis, but venous thromboembolism (VTE) remains a major postoperative complication. Most previous studies have relied solely on hospital data; no study has examined the effect of national clinical guidelines on the rates of VTE in the UK. This study aimed to assess VTE trends after arthroplasty using linked primary and secondary care data, and the impact of the National Institute for Health and Care Excellence (NICE) guidelines in the UK on VTE rates after arthroplasty. Methods: We used the Clinical Practice Research Datalink (CPRD) Aurum version, the largest primary care database in the UK, and linked hospital and death data for patients undergoing knee, hip, or shoulder arthroplasty between October 2007 and September 2019. The outcome was VTE event within six months of surgery. Trends in VTE were assessed using the Cox-Stuart trend test, and the impact of seasonality and clinical guidelines introduced in 2010, 2012, and 2018 via logistic regression with a polynomial function. Results: A total of 476,620 arthroplasty records were included. The overall VTE incidence was 1.5% (knee (1.6%), hip (1.4%), and shoulder arthroplasty (1%)). More than 30% of the VTEs were found through the linked data. A decline in VTE rates was observed over time for hip (p = 0.004) and knee arthroplasty (p = 0.001). Introduction of NICE guidelines did not significantly change the VTE rate in knee and hip arthroplasty. In shoulder arthroplasty, VTE decreased by 9% after the introduction of the 2018 guidelines. Seasonal variation in the VTE risk differed by joint. Conclusion: Future research should investigate the factors driving the seasonal association in VTE rates, and determine why shoulder arthroplasty showed a unique response after 2018. Cite this article: Bone Joint J 2026;108-B(9):1138–1146.
- 1 September 2026
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 108-B (9) , 1138-1146
Open AccessRisk of venous thromboembolism after knee, hip, or shoulder arthroplasty
Aims: Arthroplasty is a widely used surgery for end-stage arthritis, but venous thromboembolism (VTE) remains a major postoperative complication. Most previous studies have relied solely on hospital data; no study has examined the effect of national clinical guidelines on the rates of VTE in the UK. This study aimed to assess VTE trends after arthroplasty using linked primary and secondary care data, and the impact of the National Institute for Health and Care Excellence (NICE) guidelines in the UK on VTE rates after arthroplasty. Methods: We used the Clinical Practice Research Datalink (CPRD) Aurum version, the largest primary care database in the UK, and linked hospital and death data for patients undergoing knee, hip, or shoulder arthroplasty between October 2007 and September 2019. The outcome was VTE event within six months of surgery. Trends in VTE were assessed using the Cox-Stuart trend test, and the impact of seasonality and clinical guidelines introduced in 2010, 2012, and 2018 via logistic regression with a polynomial function. Results: A total of 476,620 arthroplasty records were included. The overall VTE incidence was 1.5% (knee (1.6%), hip (1.4%), and shoulder arthroplasty (1%)). More than 30% of the VTEs were found through the linked data. A decline in VTE rates was observed over time for hip (p = 0.004) and knee arthroplasty (p = 0.001). Introduction of NICE guidelines did not significantly change the VTE rate in knee and hip arthroplasty. In shoulder arthroplasty, VTE decreased by 9% after the introduction of the 2018 guidelines. Seasonal variation in the VTE risk differed by joint. Conclusion: Future research should investigate the factors driving the seasonal association in VTE rates, and determine why shoulder arthroplasty showed a unique response after 2018. Cite this article: Bone Joint J 2026;108-B(9):1138–1146.
- 31 July 2026
- Published by Royal College of General Practitioners in BJGP Open
Iron deficiency testing among people with incident heart failure in primary care
Background: Given around 50% of people with heart failure have a degree of iron deficiency, guidelines recommend screening. It is uncertain to what extent this is done in primary care and whether testing is equitable. Aim: To report the proportion of people with incident heart failure who undergo a ferritin test within 12 months. Design & setting: Retrospective primary care cohort study using Clinical Practice Research Datalink Aurum data, between 2016 and 2021. Method: We report the proportion of adults with an incident diagnosis of heart failure who received a ferritin test within 12 months. Multivariable logistic regression was used to examine the odds of testing based on key demographic covariates and co-morbidities. Results: Among 105 749 individuals with an incident diagnosis of heart failure (mean age 71.6 years, SD 14.3), only 35 688 (33.7%) received a ferritin test within the subsequent year. Increasing age (odds ratio 1.25 per 10-year increase, 95% CI: 1.24–1.27), female sex (male sex OR 0.86, 0.84–0.89) and Asian ethnicity (OR 1.70, 1.59–1.80) were all associated with increased odds of testing as were diagnoses of coeliac disease (OR 1.86, 1.58-2.21), type 1 diabetes (OR 1.82, 1.51-2.19) and cirrhosis (OR 1.64, 1.43-1.87). There was geographic variation in testing, even in adjusted analyses. Conclusion: In a large primary care dataset, two thirds of people with incident heart failure did not receive a ferritin test for iron deficiency within a year of diagnosis demonstrating a gap in current practice and an opportunity for improvements in service delivery.
- 31 July 2026
- Published by Royal College of General Practitioners in BJGP Open
Iron deficiency testing among people with incident heart failure in primary care
Background: Given around 50% of people with heart failure have a degree of iron deficiency, guidelines recommend screening. It is uncertain to what extent this is done in primary care and whether testing is equitable. Aim: To report the proportion of people with incident heart failure who undergo a ferritin test within 12 months. Design & setting: Retrospective primary care cohort study using Clinical Practice Research Datalink Aurum data, between 2016 and 2021. Method: We report the proportion of adults with an incident diagnosis of heart failure who received a ferritin test within 12 months. Multivariable logistic regression was used to examine the odds of testing based on key demographic covariates and co-morbidities. Results: Among 105 749 individuals with an incident diagnosis of heart failure (mean age 71.6 years, SD 14.3), only 35 688 (33.7%) received a ferritin test within the subsequent year. Increasing age (odds ratio 1.25 per 10-year increase, 95% CI: 1.24–1.27), female sex (male sex OR 0.86, 0.84–0.89) and Asian ethnicity (OR 1.70, 1.59–1.80) were all associated with increased odds of testing as were diagnoses of coeliac disease (OR 1.86, 1.58-2.21), type 1 diabetes (OR 1.82, 1.51-2.19) and cirrhosis (OR 1.64, 1.43-1.87). There was geographic variation in testing, even in adjusted analyses. Conclusion: In a large primary care dataset, two thirds of people with incident heart failure did not receive a ferritin test for iron deficiency within a year of diagnosis demonstrating a gap in current practice and an opportunity for improvements in service delivery.
- 14 May 2026
- Published by Royal College of General Practitioners in BJGP Open
Sociodemographic and clinical determinants of general practice consultation frequency among regular patients in Australia: a national study
Background: In Australia, general practitioners (GPs) act as gatekeepers of the healthcare system, so consultation data are essential for policy and resource allocation. However, recent national evidence linking consultation frequency with sociodemographic factors, morbidity and medication use is limited. Aim: To quantify GP consultation frequencyamong ‘regular’ patients’ attending Australian general practices, and explore associated sociodemographic and clinical factors. Design & setting: Cross-sectional study with adult ‘regular’ patients (18+years; 3+visits in two consecutive years) who attended an Australian general practice in 2021 (MedicineInsight database). Method: We performed multilevel zero-truncated negative binominal models to explore the association between the number of consultations with patient’s sociodemographic characteristics, morbidity and medications. Results: In 2021, 1 302 932 (76%) people were ‘regular’ attenders to their practice, contributing 10 806 418 consultations. The median number of consultations was 6 (IQR:3,11), with variations by sex, age group and the presence of health conditions. The model showed that being female, older, living in more disadvantaged areas, having chronic, recurrent, or acute conditions, and being prescribed medications were all associated with higher consultation rates, after adjusting for other covariates. The highest relative consultation rates were observed among people aged 75+years (IRR 2.54, 95% CI 2.48;2.61) and those with a diagnosis of chronic pain (IRR 1.82, 95% CI 1.79;1.85) or depression/anxiety (IRR 1.67, 95% CI 1.65;1.69). Conclusion: GP consultation frequency was strongly influenced by age, sex, disadvantage and morbidity, with comparatively lower attendance among younger men despite recorded health conditions. These findings highlight potential missed opportunities for monitoring, prevention and early management.
- 14 May 2026
- Published by Royal College of General Practitioners in BJGP Open
Sociodemographic and clinical determinants of general practice consultation frequency among regular patients in Australia: a national study
Background: In Australia, general practitioners (GPs) act as gatekeepers of the healthcare system, so consultation data are essential for policy and resource allocation. However, recent national evidence linking consultation frequency with sociodemographic factors, morbidity and medication use is limited. Aim: To quantify GP consultation frequencyamong ‘regular’ patients’ attending Australian general practices, and explore associated sociodemographic and clinical factors. Design & setting: Cross-sectional study with adult ‘regular’ patients (18+years; 3+visits in two consecutive years) who attended an Australian general practice in 2021 (MedicineInsight database). Method: We performed multilevel zero-truncated negative binominal models to explore the association between the number of consultations with patient’s sociodemographic characteristics, morbidity and medications. Results: In 2021, 1 302 932 (76%) people were ‘regular’ attenders to their practice, contributing 10 806 418 consultations. The median number of consultations was 6 (IQR:3,11), with variations by sex, age group and the presence of health conditions. The model showed that being female, older, living in more disadvantaged areas, having chronic, recurrent, or acute conditions, and being prescribed medications were all associated with higher consultation rates, after adjusting for other covariates. The highest relative consultation rates were observed among people aged 75+years (IRR 2.54, 95% CI 2.48;2.61) and those with a diagnosis of chronic pain (IRR 1.82, 95% CI 1.79;1.85) or depression/anxiety (IRR 1.67, 95% CI 1.65;1.69). Conclusion: GP consultation frequency was strongly influenced by age, sex, disadvantage and morbidity, with comparatively lower attendance among younger men despite recorded health conditions. These findings highlight potential missed opportunities for monitoring, prevention and early management.
- Open Access
- 18 March 2026
- Published by Elsevier in Blood Red Cells & Iron
- Vol. 2 (2)
Patterns of testing and the high burden of iron deficiency anemia in cirrhosis: a national cohort study
- 18 March 2026
- Published by Elsevier in Blood Red Cells & Iron
- Vol. 2 (2)
Open AccessPatterns of testing and the high burden of iron deficiency anemia in cirrhosis: a national cohort study
- Open Access
Effect of the English National Enhanced Service on weight management referral rate: an interrupted time-series analysis
Objectives To assess the impact of a National Enhanced Service (NES) incentive for weight management that financially rewarded practices for each eligible patient referred to a weight management programme. Design Interrupted time-series analysis to examine the rate of weight management referral and weight management advice. Setting Primary healthcare records from January 2018 to December 2024 in the Oxford Clinical Informatics Digital Hub, covering 8.3 million patients in 1198 primary care clinics around England. Interventions NES payments to practices for weight management were introduced in April 2021. Results The rate of referral increased from 1 referral per 1000 patients per month before the incentive to around 4 referrals per 1000 patients per month afterwards. There was no evidence that the increase differed by age, gender, ethnic group or socioeconomic status. The occurrence of weight management advice was unchanged by the introduction of the NES and was at least three times more common than referral to weight management services. Conclusions The NES was associated with a fourfold increase in referrals to weight management services. However, clinicians are much more likely to offer advice rather than a referral to a weight management programme. There is a clear opportunity to improve outcomes for patients by encouraging greater use of referrals to effective weight management services in place of advice.
Open AccessEffect of the English National Enhanced Service on weight management referral rate: an interrupted time-series analysis
Objectives To assess the impact of a National Enhanced Service (NES) incentive for weight management that financially rewarded practices for each eligible patient referred to a weight management programme. Design Interrupted time-series analysis to examine the rate of weight management referral and weight management advice. Setting Primary healthcare records from January 2018 to December 2024 in the Oxford Clinical Informatics Digital Hub, covering 8.3 million patients in 1198 primary care clinics around England. Interventions NES payments to practices for weight management were introduced in April 2021. Results The rate of referral increased from 1 referral per 1000 patients per month before the incentive to around 4 referrals per 1000 patients per month afterwards. There was no evidence that the increase differed by age, gender, ethnic group or socioeconomic status. The occurrence of weight management advice was unchanged by the introduction of the NES and was at least three times more common than referral to weight management services. Conclusions The NES was associated with a fourfold increase in referrals to weight management services. However, clinicians are much more likely to offer advice rather than a referral to a weight management programme. There is a clear opportunity to improve outcomes for patients by encouraging greater use of referrals to effective weight management services in place of advice.
- Open Access
- 7 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e69874
Adoption of an Electronic Decision Support Tool for Capacity Building of Community Health Workers: Mixed Methods Study
Background: Complimentary subscriptions to UpToDate, a decision support tool, were provided to community health workers (CHWs) in rural and remote primary care sites as part of a government-funded health system research program. A feasibility evaluation conducted after the first year of implementation showed that UpToDate was acceptable among CHWs despite infrastructural barriers. Objective: This follow-up study evaluated the longitudinal adoption of UpToDate among CHWs and examined how sociocultural, political, and environmental factors influenced its use. Drawing on the nonadoption, abandonment, scale-up, spread, and sustainability framework, this study aimed to understand not only use patterns but also broader challenges to scale-up, spread, and sustainability in a complex health system. Methods: An explanatory mixed methods design was used combining analysis of use and program activity logs; program reports; and focus groups with CHWs, health care professionals, and program implementers. Quantitative analysis of use logs (March 2021 to September 2023) compared adoption over time by using descriptive statistics, CIs, and chi-square tests. Qualitative data came from the reanalysis of previous focus group transcripts and program reports and from a new focus group with program implementers. Reflexive thematic analysis was used to interpret how CHWs and implementers perceived and used the tool, and findings were integrated to explain quantitative trends. Results: Use of UpToDate was modest and declined over time. Monthly active use among CHWs and midwives fell substantially from 3.57% (97/2720 person-months) in 2021 to 1.07% (37/3456) in 2022 and remained low at 1.50% (39/2592) up to 2023, with markedly higher engagement in the rural site than in the remote site. Peaks in use coincided with program activities, whereas prolonged troughs followed typhoons, power outages, and other disruptions. Log data showed that users primarily consulted patient education articles rather than clinician-oriented decision tools. Qualitative analyses revealed that CHWs appropriated UpToDate as a learning aid and source of professional credibility. Structural shocks, heavy workloads, language barriers, and limited device access constrained individual use, and communal practices (shared devices and learning activities) meant that meaningful engagement often went unrecorded in vendor metrics. Conclusions: Our findings show that acceptability does not guarantee sustained use and that adoption cannot be captured fully by log-in counts. UpToDate’s value for CHWs lay in how it was domesticated as a tool for building capacity and professional credibility, not in its intended function as a decision aid used at the point of care. Therefore, evaluations of digital health tools should incorporate indicators of learning and social capital alongside use metrics. Policymakers should recognize that infrastructural fragility and communal adaptation shape digital health uptake. Embedding tools into ongoing training and peer learning structures, providing offline and multilingual support, and investing in resilience planning will be crucial for meaningful scale-up and sustainability.
- 7 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e69874
Open AccessAdoption of an Electronic Decision Support Tool for Capacity Building of Community Health Workers: Mixed Methods Study
Background: Complimentary subscriptions to UpToDate, a decision support tool, were provided to community health workers (CHWs) in rural and remote primary care sites as part of a government-funded health system research program. A feasibility evaluation conducted after the first year of implementation showed that UpToDate was acceptable among CHWs despite infrastructural barriers. Objective: This follow-up study evaluated the longitudinal adoption of UpToDate among CHWs and examined how sociocultural, political, and environmental factors influenced its use. Drawing on the nonadoption, abandonment, scale-up, spread, and sustainability framework, this study aimed to understand not only use patterns but also broader challenges to scale-up, spread, and sustainability in a complex health system. Methods: An explanatory mixed methods design was used combining analysis of use and program activity logs; program reports; and focus groups with CHWs, health care professionals, and program implementers. Quantitative analysis of use logs (March 2021 to September 2023) compared adoption over time by using descriptive statistics, CIs, and chi-square tests. Qualitative data came from the reanalysis of previous focus group transcripts and program reports and from a new focus group with program implementers. Reflexive thematic analysis was used to interpret how CHWs and implementers perceived and used the tool, and findings were integrated to explain quantitative trends. Results: Use of UpToDate was modest and declined over time. Monthly active use among CHWs and midwives fell substantially from 3.57% (97/2720 person-months) in 2021 to 1.07% (37/3456) in 2022 and remained low at 1.50% (39/2592) up to 2023, with markedly higher engagement in the rural site than in the remote site. Peaks in use coincided with program activities, whereas prolonged troughs followed typhoons, power outages, and other disruptions. Log data showed that users primarily consulted patient education articles rather than clinician-oriented decision tools. Qualitative analyses revealed that CHWs appropriated UpToDate as a learning aid and source of professional credibility. Structural shocks, heavy workloads, language barriers, and limited device access constrained individual use, and communal practices (shared devices and learning activities) meant that meaningful engagement often went unrecorded in vendor metrics. Conclusions: Our findings show that acceptability does not guarantee sustained use and that adoption cannot be captured fully by log-in counts. UpToDate’s value for CHWs lay in how it was domesticated as a tool for building capacity and professional credibility, not in its intended function as a decision aid used at the point of care. Therefore, evaluations of digital health tools should incorporate indicators of learning and social capital alongside use metrics. Policymakers should recognize that infrastructural fragility and communal adaptation shape digital health uptake. Embedding tools into ongoing training and peer learning structures, providing offline and multilingual support, and investing in resilience planning will be crucial for meaningful scale-up and sustainability.
- Open Access
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11 (1) , e70275
Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal
Background: Blood tests used to identify patients at increased risk of undiagnosed cancer are commonly used in isolation, primarily by monitoring whether results fall outside the normal range. Some prediction models incorporate changes over repeated blood tests (or trends) to improve individualized cancer risk identification, as relevant trends may be confined within the normal range. Objective: Our aim was to critically appraise existing diagnostic prediction models incorporating blood test trends for the risk of cancer. Methods: MEDLINE and EMBASE were searched until April 3, 2025 for diagnostic prediction model studies using blood test trends for cancer risk. Screening was performed by 4 reviewers. Data extraction for each article was performed by 2 reviewers independently. To critically appraise models, we narratively synthesized studies, including model building and validation strategies, model reporting, and the added value of blood test trends. We also reviewed the performance measures of each model, including discrimination and calibration. We performed a random-effects meta-analysis of the c-statistic for a trends-based prediction model if there were at least 3 studies validating the model. The risk of bias was assessed using the PROBAST (prediction model risk of bias assessment tool). Results: We included 16 articles, with a total of 7 models developed and 14 external validation studies. In the 7 models derived, full blood count (FBC) trends were most commonly used (86%, n=7 models). Cancers modeled were colorectal (43%, n=3), gastro-intestinal (29%, n=2), nonsmall cell lung (14%, n=1), and pancreatic (14%, n=1). In total, 2 models used statistical logistic regression, 2 used joint modeling, and 1 each used XGBoost, decision trees, and random forests. The number of blood test trends included in the models ranged from 1 to 26. A total of 2 of 4 models were reported with the full set of coefficients needed to predict risk, with the remaining excluding at least one coefficient from their article or were not publicly accessible. The c-statistic ranged 0.69‐0.87 among validation studies. The ColonFlag model using trends in the FBC was commonly externally validated, with a pooled c-statistic=0.81 (95% CI 0.77-0.85; n=4 studies) for 6-month colorectal cancer risk. Models were often inadequately tested, with only one external validation study assessing model calibration. All 16 studies scored a low risk of bias regarding predictor and outcome details. All but one study scored a high risk of bias in the analysis domain, with most studies often removing patients with missing data from analysis or not adjusting the derived model for overfitting. Conclusions: Our review highlights that blood test trends may inform further investigation for cancer. However, models were not available for most cancer sites, were rarely externally validated, and rarely assessed calibration when they were externally validated.
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11 (1) , e70275
Open AccessClinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal
Background: Blood tests used to identify patients at increased risk of undiagnosed cancer are commonly used in isolation, primarily by monitoring whether results fall outside the normal range. Some prediction models incorporate changes over repeated blood tests (or trends) to improve individualized cancer risk identification, as relevant trends may be confined within the normal range. Objective: Our aim was to critically appraise existing diagnostic prediction models incorporating blood test trends for the risk of cancer. Methods: MEDLINE and EMBASE were searched until April 3, 2025 for diagnostic prediction model studies using blood test trends for cancer risk. Screening was performed by 4 reviewers. Data extraction for each article was performed by 2 reviewers independently. To critically appraise models, we narratively synthesized studies, including model building and validation strategies, model reporting, and the added value of blood test trends. We also reviewed the performance measures of each model, including discrimination and calibration. We performed a random-effects meta-analysis of the c-statistic for a trends-based prediction model if there were at least 3 studies validating the model. The risk of bias was assessed using the PROBAST (prediction model risk of bias assessment tool). Results: We included 16 articles, with a total of 7 models developed and 14 external validation studies. In the 7 models derived, full blood count (FBC) trends were most commonly used (86%, n=7 models). Cancers modeled were colorectal (43%, n=3), gastro-intestinal (29%, n=2), nonsmall cell lung (14%, n=1), and pancreatic (14%, n=1). In total, 2 models used statistical logistic regression, 2 used joint modeling, and 1 each used XGBoost, decision trees, and random forests. The number of blood test trends included in the models ranged from 1 to 26. A total of 2 of 4 models were reported with the full set of coefficients needed to predict risk, with the remaining excluding at least one coefficient from their article or were not publicly accessible. The c-statistic ranged 0.69‐0.87 among validation studies. The ColonFlag model using trends in the FBC was commonly externally validated, with a pooled c-statistic=0.81 (95% CI 0.77-0.85; n=4 studies) for 6-month colorectal cancer risk. Models were often inadequately tested, with only one external validation study assessing model calibration. All 16 studies scored a low risk of bias regarding predictor and outcome details. All but one study scored a high risk of bias in the analysis domain, with most studies often removing patients with missing data from analysis or not adjusting the derived model for overfitting. Conclusions: Our review highlights that blood test trends may inform further investigation for cancer. However, models were not available for most cancer sites, were rarely externally validated, and rarely assessed calibration when they were externally validated.
- Open Access
- 10 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Adoption of an Electronic Decision Support Tool for Capacity Building of Community Health Workers: Mixed Methods Study (Preprint)
BACKGROUND Complimentary subscriptions to UpToDate, a decision support tool, were provided to community health workers (CHWs) in rural and remote primary care sites as part of a government-funded health system research program. A feasibility evaluation conducted after the first year of implementation showed that UpToDate was acceptable among CHWs despite infrastructural barriers. OBJECTIVE This follow-up study evaluated the longitudinal adoption of UpToDate among CHWs and examined how sociocultural, political, and environmental factors influenced its use. Drawing on the nonadoption, abandonment, scale-up, spread, and sustainability framework, this study aimed to understand not only use patterns but also broader challenges to scale-up, spread, and sustainability in a complex health system. METHODS An explanatory mixed methods design was used combining analysis of use and program activity logs; program reports; and focus groups with CHWs, health care professionals, and program implementers. Quantitative analysis of use logs (March 2021 to September 2023) compared adoption over time by using descriptive statistics, CIs, and chi-square tests. Qualitative data came from the reanalysis of previous focus group transcripts and program reports and from a new focus group with program implementers. Reflexive thematic analysis was used to interpret how CHWs and implementers perceived and used the tool, and findings were integrated to explain quantitative trends. RESULTS Use of UpToDate was modest and declined over time. Monthly active use among CHWs and midwives fell substantially from 3.57% (97/2720 person-months) in 2021 to 1.07% (37/3456) in 2022 and remained low at 1.50% (39/2592) up to 2023, with markedly higher engagement in the rural site than in the remote site. Peaks in use coincided with program activities, whereas prolonged troughs followed typhoons, power outages, and other disruptions. Log data showed that users primarily consulted patient education articles rather than clinician-oriented decision tools. Qualitative analyses revealed that CHWs appropriated UpToDate as a learning aid and source of professional credibility. Structural shocks, heavy workloads, language barriers, and limited device access constrained individual use, and communal practices (shared devices and learning activities) meant that meaningful engagement often went unrecorded in vendor metrics. CONCLUSIONS Our findings show that acceptability does not guarantee sustained use and that adoption cannot be captured fully by log-in counts. UpToDate’s value for CHWs lay in how it was domesticated as a tool for building capacity and professional credibility, not in its intended function as a decision aid used at the point of care. Therefore, evaluations of digital health tools should incorporate indicators of learning and social capital alongside use metrics. Policymakers should recognize that infrastructural fragility and communal adaptation shape digital health uptake. Embedding tools into ongoing training and peer learning structures, providing offline and multilingual support, and investing in resilience planning will be crucial for meaningful scale-up and sustainability.
- 10 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAdoption of an Electronic Decision Support Tool for Capacity Building of Community Health Workers: Mixed Methods Study (Preprint)
BACKGROUND Complimentary subscriptions to UpToDate, a decision support tool, were provided to community health workers (CHWs) in rural and remote primary care sites as part of a government-funded health system research program. A feasibility evaluation conducted after the first year of implementation showed that UpToDate was acceptable among CHWs despite infrastructural barriers. OBJECTIVE This follow-up study evaluated the longitudinal adoption of UpToDate among CHWs and examined how sociocultural, political, and environmental factors influenced its use. Drawing on the nonadoption, abandonment, scale-up, spread, and sustainability framework, this study aimed to understand not only use patterns but also broader challenges to scale-up, spread, and sustainability in a complex health system. METHODS An explanatory mixed methods design was used combining analysis of use and program activity logs; program reports; and focus groups with CHWs, health care professionals, and program implementers. Quantitative analysis of use logs (March 2021 to September 2023) compared adoption over time by using descriptive statistics, CIs, and chi-square tests. Qualitative data came from the reanalysis of previous focus group transcripts and program reports and from a new focus group with program implementers. Reflexive thematic analysis was used to interpret how CHWs and implementers perceived and used the tool, and findings were integrated to explain quantitative trends. RESULTS Use of UpToDate was modest and declined over time. Monthly active use among CHWs and midwives fell substantially from 3.57% (97/2720 person-months) in 2021 to 1.07% (37/3456) in 2022 and remained low at 1.50% (39/2592) up to 2023, with markedly higher engagement in the rural site than in the remote site. Peaks in use coincided with program activities, whereas prolonged troughs followed typhoons, power outages, and other disruptions. Log data showed that users primarily consulted patient education articles rather than clinician-oriented decision tools. Qualitative analyses revealed that CHWs appropriated UpToDate as a learning aid and source of professional credibility. Structural shocks, heavy workloads, language barriers, and limited device access constrained individual use, and communal practices (shared devices and learning activities) meant that meaningful engagement often went unrecorded in vendor metrics. CONCLUSIONS Our findings show that acceptability does not guarantee sustained use and that adoption cannot be captured fully by log-in counts. UpToDate’s value for CHWs lay in how it was domesticated as a tool for building capacity and professional credibility, not in its intended function as a decision aid used at the point of care. Therefore, evaluations of digital health tools should incorporate indicators of learning and social capital alongside use metrics. Policymakers should recognize that infrastructural fragility and communal adaptation shape digital health uptake. Embedding tools into ongoing training and peer learning structures, providing offline and multilingual support, and investing in resilience planning will be crucial for meaningful scale-up and sustainability.
- Open Access
- 10 December 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 75 (753) , e232-e240
Prevalence and patterns of testing for anaemia in primary care in England: a cohort study using an electronic health records database
Background: Despite epidemiological data on anaemia being available on a global scale, the prevalence of anaemia in the UK is not well described. Aim: To describe anaemia prevalence and testing patterns for haemoglobin and other blood parameters. Design and setting: This study was a descriptive population-based cohort study using data drawn from the Clinical Practice Research Datalink Aurum database in 2019. Method: Demographic data were extracted for each person who was registered at their current practice during 2019, including linked data on Index of Multiple Deprivation. Anaemia prevalence in 2019 was calculated based on World Health Organization-specified age and gender thresholds for haemoglobin. Anaemia was classified based on mean corpuscular volume and ferritin. People with anaemia were followed up for up to 1 year to investigate longitudinal testing patterns for haemoglobin. Results: The cohort contained 14 million people. Anaemia prevalence in England in 2019 was 4.1% (583 847/14 207 841) (5.1% [363 438/7 121 614] females and 3.1% [220 409/7 086 227] males). Prevalence was higher in people aged >65 years, people of Black and Asian ethnicities, and people living in areas with higher social deprivation. Only half of people with anaemia and a mean corpuscular volume of ≤100 fL had an accompanying ferritin value recorded. About half of people with anaemia had a follow-up haemoglobin test within 1 year, most of which still indicated anaemia. Conclusion: Anaemia is prevalent in the UK with large disparities between levels of demographic variables. Investigation and follow-up of anaemia is suboptimal in many patients. Health interventions aimed at improving anaemia investigation and treatment are needed, particularly in the most at-risk groups.
- 10 December 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 75 (753) , e232-e240
Open AccessPrevalence and patterns of testing for anaemia in primary care in England: a cohort study using an electronic health records database
Background: Despite epidemiological data on anaemia being available on a global scale, the prevalence of anaemia in the UK is not well described. Aim: To describe anaemia prevalence and testing patterns for haemoglobin and other blood parameters. Design and setting: This study was a descriptive population-based cohort study using data drawn from the Clinical Practice Research Datalink Aurum database in 2019. Method: Demographic data were extracted for each person who was registered at their current practice during 2019, including linked data on Index of Multiple Deprivation. Anaemia prevalence in 2019 was calculated based on World Health Organization-specified age and gender thresholds for haemoglobin. Anaemia was classified based on mean corpuscular volume and ferritin. People with anaemia were followed up for up to 1 year to investigate longitudinal testing patterns for haemoglobin. Results: The cohort contained 14 million people. Anaemia prevalence in England in 2019 was 4.1% (583 847/14 207 841) (5.1% [363 438/7 121 614] females and 3.1% [220 409/7 086 227] males). Prevalence was higher in people aged >65 years, people of Black and Asian ethnicities, and people living in areas with higher social deprivation. Only half of people with anaemia and a mean corpuscular volume of ≤100 fL had an accompanying ferritin value recorded. About half of people with anaemia had a follow-up haemoglobin test within 1 year, most of which still indicated anaemia. Conclusion: Anaemia is prevalent in the UK with large disparities between levels of demographic variables. Investigation and follow-up of anaemia is suboptimal in many patients. Health interventions aimed at improving anaemia investigation and treatment are needed, particularly in the most at-risk groups.